Text: H.R.6019 — 116th Congress (2019-2020)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (02/28/2020)


116th CONGRESS
2d Session
H. R. 6019


To expand the tropical disease product priority review voucher program to encourage treatments for coronavirus.


IN THE HOUSE OF REPRESENTATIVES

February 28, 2020

Mr. Jeffries (for himself, Mr. King of New York, Mr. Cárdenas, and Ms. Herrera Beutler) introduced the following bill; which was referred to the Committee on Energy and Commerce


A BILL

To expand the tropical disease product priority review voucher program to encourage treatments for coronavirus.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Cure the Coronavirus Act”.

SEC. 2. Expanding tropical disease product priority review voucher program to encourage treatments for coronavirus.

Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended—

(1) by redesignating subparagraph (S) as subparagraph (T); and

(2) by inserting after subparagraph (R) the following:

    “(S) The 2019 novel coronavirus (COVID–19).”.


Share This